查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1225476

视网膜母细胞瘤治疗市场：按类型（手术,放射疗法,激光疗法,冷冻疗法,热疗,化疗,眼动脉灌注化疗,大剂量化疗/干细胞移植）,阶段,应用,地区2023-2028

Retinoblastoma Treatment Market by Type(Surgery, Radiation Therapy, Laser Therapy, Cryotherapy, Thermotherapy, Chemotherapy, Opthalmic Artery Infusion Chemotherapy, High-Dose Chemotherapy & Stem Cell Transplant, Staging) Application & Region 2023-2028
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

市场概览

  • 到 2022 年，全球视网膜母细胞瘤治疗市场规模将达到 27 亿美元。 展望未来，IMARC Group 预测到 2028 年将达到 35 亿美元，2023 年至 2028 年的增长率 (CAGR) 为 4.2%。 眼科治疗的医疗费用显着增加,对副作用较小的治疗的研发活动的投资增加以及健康意识的提高是推动市场的一些主要因素。
  • 视网膜母细胞瘤是最常见的癌症之一，通常发生在五岁以下的儿童身上。 视网膜母细胞瘤的症状包括猫眼反射和称为白斑的瞳孔混浊。 视网膜母细胞瘤有多种药物输送和化学疗法，并且由于视网膜母细胞瘤在早期是可以治癒的，因此可以在短时间内见效。 在第一个或第二个化疗週期后，可以应用不同的局部治疗，具体取决于肿瘤的大小及其在眼内的位置。 不同治疗的组合是治疗视网膜母细胞瘤最成功的方法。 手术是视网膜母细胞瘤的永久性治疗方法，因为它可以将肿瘤从视网膜上完全切除。 视网膜母细胞瘤的详细诊断包括各种影像学检查，包括超声,CT 扫描,MRI,X 射线和骨扫描。

视网膜母细胞瘤治疗市场趋势

  • 用于眼部护理程序的医疗保健支出显着增加是推动市场发展的一个关键因素。 这是由于年轻人视网膜母细胞瘤的发病率上升。 与此同时，增加对副作用更少的更有效治疗的研发投资也在振兴市场。 此外，对不同类型癌症的认识提高以及诊断和治疗率的提高也是重要的增长动力。 然而，各种视网膜母细胞瘤治疗的不可用性和严格的监管规定正在限制市场的增长。 另一方面，越来越多的产品批准导致新药上市，给市场带来了光明的前景。 除此之外，视网膜母细胞瘤復发率的增加也为视网膜母细胞瘤治疗市场创造了有利可图的机会。 此外，主要付款人实施的各种有机增长战略，如合作伙伴关係,联盟和併购 (M&A) 正在推动市场。 除此之外，强大的管道药物的存在和越来越多的临床试验正在推动市场增长。 推动市场增长的其他因素包括快速城市化,可支配收入水平上升,癌症研究显着增加以及全球医疗基础设施的改善。

主要市场细分

  • IMARC Group 分析了全球视网膜母细胞瘤治疗市场每个细分市场的主要趋势，并提供了 2023 年至 2028 年全球,区域和国家层面的预测。 该报告根据类型,治疗类型,分期类型和应用对市场进行细分。

类型洞察

  • 非系视网膜母细胞瘤
  • 遗传性视网膜母细胞瘤
  • 本报告按类型对视网膜母细胞瘤治疗市场进行了详细细分和分析。 这包括非遗传性视网膜母细胞瘤和遗传性视网膜母细胞瘤。 另外，非遗传性视网膜母细胞瘤占最大部分。

治疗类型见解

  • 手术
  • 放射治疗
  • 激光治疗（光凝）
  • 冷冻疗法
  • 热疗
  • 化疗
  • 眼动脉注射化疗
  • 大剂量化疗和干细胞移植
  • 本报告根据治疗类型对视网膜母细胞瘤治疗市场进行了详细的细分和分析。 这包括手术,放射疗法,激光疗法（光凝）,冷冻疗法,热疗,化学疗法,眼动脉注射化学疗法,大剂量化学疗法和干细胞移植。 除此之外，化学疗法占最大部分。

暂存见解的类型

  • 眼内视网膜母细胞瘤
  • 眼外视网膜母细胞瘤
  • 本报告根据分期类型对视网膜母细胞瘤治疗市场进行了详细细分和分析。 这包括眼内视网膜母细胞瘤和眼外视网膜母细胞瘤。 根据这份报告，眼内视网膜母细胞瘤占最大部分。

应用洞察

  • 医院
  • 癌症研究所
  • 其他
  • 报告还提供了基于应用的视网膜母细胞瘤治疗市场的详细细分和分析。 这包括医院,癌症研究机构等。

地理洞察

  • 北美
  • 美国
  • 加拿大
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳大利亚
  • 印度尼西亚
  • 其他
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 意大利
  • 西班牙
  • 俄罗斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中东和非洲
  • 北美（美国,加拿大）,亚太地区（中国,日本,印度,韩国,澳大利亚,印度尼西亚等）,欧洲（德国,法国,英国,意大利,西班牙,俄罗斯等）,南美国（巴西）,墨西哥等）,中东,非洲综合分析。 除此之外，亚太地区是视网膜母细胞瘤治疗的最大市场。 亚太地区视网膜母细胞瘤治疗市场的驱动因素是视网膜母细胞瘤的复发率上升，对不同类型癌症的认识提高导致更高的诊断和治疗率，以及多个和大公司的存在

本报告中回答的关键问题

  • 全球视网膜母细胞瘤治疗市场到目前为止表现如何，未来几年会是什么样子？
  • 全球视网膜母细胞瘤治疗市场的驱动因素,制约因素和机遇是什么？
  • 您的主要区域市场是什么？
  • 哪个国家/地区代表了最具吸引力的视网膜母细胞瘤治疗市场？
  • 按类型划分的市场细分情况如何？
  • 按治疗类型划分的市场细分情况如何？
  • 基于疾病分期的市场细分是什么？
  • 基于应用的市场细分是什么？
  • 全球视网膜母细胞瘤治疗市场的竞争结构如何？
  • 全球视网膜母细胞瘤治疗市场的主要参与者/公司有哪些？

内容

第1章前言

第 2 章研究方法和范围

  • 调查的目的
  • 利益相关者
  • 数据来源
    • 主要信息
    • 次要信息
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章执行摘要

第4章介绍

  • 概览
  • 主要行业趋势

第 5 章全球视网膜母细胞瘤治疗市场

  • 市场概览
  • 市场结果
  • COVID-19 的影响
  • 市场预测

第 6 章按类型划分的市场细分

  • 非干酪性视网膜母细胞瘤
    • 市场趋势
    • 市场预测
  • 遗传性视网膜母细胞瘤
    • 市场趋势
    • 市场预测

第 7 章按治疗类型划分的市场细分

  • 手术
    • 市场趋势
    • 市场预测
  • 放射治疗
    • 市场趋势
    • 市场预测
  • 激光治疗（光凝）
    • 市场趋势
    • 市场展望
  • 冷冻疗法
    • 市场趋势
    • 市场展望
  • 热疗
    • 市场趋势
    • 市场预测
  • 化疗
    • 市场趋势
    • 市场预测
  • 眼动脉注射化疗
    • 市场趋势
    • 市场展望
  • 大剂量化疗/干细胞移植
    • 市场趋势
    • 市场预测

第 8 章按阶段类型划分的市场细分

  • 眼内视网膜母细胞瘤
    • 市场趋势
    • 市场预测
  • 眼外视网膜母细胞瘤
    • 市场趋势
    • 市场展望

第 9 章按应用划分的市场细分

  • 医院
    • 市场趋势
    • 市场预测
  • 癌症研究所
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第 10 章区域市场细分

  • 北美
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场展望
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场展望
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场展望
    • 韩国市场
      • 市场趋势
      • 市场展望
    • 澳大利亚
      • 市场趋势
      • 市场展望
    • 印度尼西亚
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场展望
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场展望
    • 西班牙
      • 市场趋势
      • 市场展望
    • 俄罗斯
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场展望
    • 墨西哥
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家/地区划分的市场细分
    • 市场展望

第 11 章：驱动因素,阻碍因素和机遇

  • 概览
  • 司机
  • 抑製剂条件
  • 商机

第12章价值链分析

第13章搬运工五力分析

  • 概览
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第14章价格分析

第15章竞争格局

  • 市场结构
  • 主要公司
  • 主要公司简介
    • Bristol Myers Squibb Company
    • Pfizer Inc.
    • Teva Canada Limited（Teva Pharmaceutical Industries Ltd.）

本报告所列公司仅为部分，所有公司名称均包含在本报告中。

Product Code: SR1423A317_Report

Market Overview:

  • The global retinoblastoma treatment market size reached US$ 2.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.2% during 2023-2028. A considerable rise in healthcare expenditure for ophthalmic treatment procedures, increasing investments in research and development (R&D) activities on therapies with lower side effects, and the increasing health consciousness represent some of the key factors driving the market.
  • Retinoblastoma is one of the most common cancers that generally develops before the age of 5 in children. Some of the symptoms of retinoblastoma include a white appearance in the pupil called cat's eye reflex or leukocoria. Retinoblastoma treatment can include a variety of drug delivery and chemotherapy techniques that provide some benefits in the short term since retinoblastoma is curable at the initial stage. Following the first or second chemotherapy cycle, different focal treatments can then be applied depending on how much the tumor shrinks and where it is in the eye. A combination of different treatment methods is the most successful retinoblastoma treatment option. Surgery is the permanent retinoblastoma treatment option as it removes the tumor thoroughly from the retina. There are a variety of imaging tests available for a detailed diagnosis of retinoblastoma, including ultrasound, CT-scan, MRI, X-ray, and bone scan.

Retinoblastoma Treatment Market Trends:

  • A considerable rise in healthcare expenditure for ophthalmic treatment procedures is a significant factor driving the market. This can be attributed to the rising incidences of retinoblastoma among the younger population. In line with this, increasing investments in research and development (R&D) activities focusing on newer, more efficient therapeutic strategies with lesser associated side effects is providing an impetus to the market. Moreover, the growing awareness regarding different type of cancers resulting in higher diagnosis and treatment rates are also acting as a significant growth-inducing factor. However, the lack of availability of various retinoblastoma treatment drugs, along with stringent drug regulations, are acting as a growth-restraining factor for the market. On the contrary, the increasing number of product approvals leading to the launches of new drug variants is creating a positive outlook for the market. Besides this, the growing rates of recurrence of retinoblastoma are also creating lucrative opportunities in the retinoblastoma treatment market. The market is further propelled by various organic growth strategies undertaken by key payers, such as partnerships and collaborations, and merger and acquisitions (M&As). Apart from this, the presence of strong pipeline drugs, along with the augmenting number of clinical trials, are fueling the market growth. Some of the other factors contributing to the market include rapid urbanization, inflating disposable income levels, considerable growth in cancer research, and improvements in medical infrastructure across the globe.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each segment of the global retinoblastoma treatment market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on type, treatment type, type of staging, and application.

Type Insights:

  • Non-Hereditary Retinoblastoma
  • Hereditary Retinoblastoma
  • The report has provided a detailed breakup and analysis of the retinoblastoma treatment market based on the type. This includes non-hereditary retinoblastoma and hereditary retinoblastoma. According to the report, non-hereditary retinoblastoma represented the largest segment.

Treatment Type Insights:

  • Surgery
  • Radiation Therapy
  • Laser Therapy (Photocoagulation)
  • Cryotherapy
  • Thermotherapy
  • Chemotherapy
  • Opthalmic Artery Infusion Chemotherapy
  • High-Dose Chemotherapy and Stem Cell Transplant
  • The report has provided a detailed breakup and analysis of the retinoblastoma treatment market based on the treatment type. This includes surgery, radiation therapy, laser therapy (photocoagulation), cryotherapy, thermotherapy, chemotherapy, opthalmic artery infusion chemotherapy, and high-dose chemotherapy and stem cell transplant. According to the report, chemotherapy represented the largest segment.

Type of Staging Insights:

  • Intraocular Retinoblastoma
  • Extraocular Retinoblastoma
  • The report has provided a detailed breakup and analysis of the retinoblastoma treatment market based on the type of staging. This includes intraocular retinoblastoma and extraocular retinoblastoma. According to the report, intraocular retinoblastoma represented the largest segment.

Application Insights:

  • Hospitals
  • Cancer Institutes
  • Others
  • A detailed breakup and analysis of the retinoblastoma treatment market based on the application has also been provided in the report. This includes hospitals, cancer institutes, and others.

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific was the largest market for retinoblastoma treatment. Some of the factors driving the Asia Pacific retinoblastoma treatment market include the growing rates of recurrence of retinoblastoma, higher diagnosis and treatment rates due to the increasing awareness regarding different types of cancers, the presence of several key players in the region, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global retinoblastoma treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Bristol Myers Squibb Company, Pfizer Inc., Teva Canada Limited (Teva Pharmaceutical Industries Ltd.), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global retinoblastoma treatment market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global retinoblastoma treatment market?
  • What are the key regional markets?
  • Which countries represent the most attractive retinoblastoma treatment markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the type of staging?
  • What is the breakup of the market based on application?
  • What is the competitive structure of the global retinoblastoma treatment market?
  • Who are the key players/companies in the global retinoblastoma treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Retinoblastoma Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Non-Hereditary Retinoblastoma
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hereditary Retinoblastoma
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Surgery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Radiation Therapy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Laser Therapy (Photocoagulation)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cryotherapy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Thermotherapy
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Chemotherapy
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Opthalmic Artery Infusion Chemotherapy
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 High-Dose Chemotherapy and Stem Cell Transplant
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by Type of Staging

  • 8.1 Intraocular Retinoblastoma
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Extraocular Retinoblastoma
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Cancer Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bristol Myers Squibb Company
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Pfizer Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Teva Canada Limited (Teva Pharmaceutical Industries Ltd.)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Retinoblastoma Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Retinoblastoma Treatment Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Retinoblastoma Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Retinoblastoma Treatment Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Retinoblastoma Treatment Market: Breakup by Treatment Type (in %), 2022
  • Figure 6: Global: Retinoblastoma Treatment Market: Breakup by Type of Staging (in %), 2022
  • Figure 7: Global: Retinoblastoma Treatment Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Retinoblastoma Treatment Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Retinoblastoma Treatment (Non-Hereditary Retinoblastoma) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Retinoblastoma Treatment (Non-Hereditary Retinoblastoma) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Retinoblastoma Treatment (Hereditary Retinoblastoma) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Retinoblastoma Treatment (Hereditary Retinoblastoma) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Retinoblastoma Treatment (Surgery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Retinoblastoma Treatment (Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Retinoblastoma Treatment (Radiation Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Retinoblastoma Treatment (Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Retinoblastoma Treatment (Laser Therapy (Photocoagulation)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Retinoblastoma Treatment (Laser Therapy (Photocoagulation)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Retinoblastoma Treatment (Cryotherapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Retinoblastoma Treatment (Cryotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Retinoblastoma Treatment (Thermotherapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Retinoblastoma Treatment (Thermotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Retinoblastoma Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Retinoblastoma Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Retinoblastoma Treatment (Opthalmic Artery Infusion Chemotherapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Retinoblastoma Treatment (Opthalmic Artery Infusion Chemotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Retinoblastoma Treatment (High-Dose Chemotherapy and Stem Cell Transplant) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Retinoblastoma Treatment (High-Dose Chemotherapy and Stem Cell Transplant) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Retinoblastoma Treatment (Intraocular Retinoblastoma) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Retinoblastoma Treatment (Intraocular Retinoblastoma) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Retinoblastoma Treatment (Extraocular Retinoblastoma) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Retinoblastoma Treatment (Extraocular Retinoblastoma) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Retinoblastoma Treatment (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Retinoblastoma Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Retinoblastoma Treatment (Cancer Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Retinoblastoma Treatment (Cancer Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Retinoblastoma Treatment (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Retinoblastoma Treatment (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: North America: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: North America: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: United States: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: United States: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Canada: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Canada: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Asia-Pacific: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Asia-Pacific: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: China: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: China: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Japan: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Japan: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: India: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: India: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: South Korea: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: South Korea: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Australia: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Australia: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Indonesia: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Indonesia: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Europe: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Europe: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Germany: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Germany: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: France: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: France: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: United Kingdom: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: United Kingdom: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Italy: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Italy: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Spain: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Spain: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Russia: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Russia: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Latin America: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Latin America: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Brazil: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Brazil: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Mexico: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Mexico: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Others: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Others: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Middle East and Africa: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Middle East and Africa: Retinoblastoma Treatment Market: Breakup by Country (in %), 2022
  • Figure 87: Middle East and Africa: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Global: Retinoblastoma Treatment Industry: Drivers, Restraints, and Opportunities
  • Figure 89: Global: Retinoblastoma Treatment Industry: Value Chain Analysis
  • Figure 90: Global: Retinoblastoma Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Retinoblastoma Treatment Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Retinoblastoma Treatment Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Retinoblastoma Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
  • Table 4: Global: Retinoblastoma Treatment Market Forecast: Breakup by Type of Staging (in Million US$), 2023-2028
  • Table 5: Global: Retinoblastoma Treatment Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Retinoblastoma Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Retinoblastoma Treatment Market: Competitive Structure
  • Table 8: Global: Retinoblastoma Treatment Market: Key Players